SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pluristem Therapeutics
PSTI 8.720+0.2%Aug 14 5:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: xcentral112/29/2010 8:36:59 AM
   of 295
 
FYI:

Pluristem Therapeutics Inc. Key Recent Developments

Mar 03, 2010: Receives DSMB Approval To Advance Final Dose Level With PLX-PAD
Feb 03, 2010: Pluristem Reports Positive PLX Cell Study Results
Sep 10, 2009: Pluristem Initiates Enrollment In Phase I Clinical trial For PLX-PAD In US
Jul 07, 2009: Pluristem Initiates Phase-I CLI Trial
Jun 02, 2009: Pluristem Therapeutics Appoints John Cooke To Its Scientific

should move soon...... ~)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News